ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer

Oncology Learning Network

16/02/2023 7 min

Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer

Listen "Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer"

Descargar episodio

Episode Synopsis

Sara Hurvitz, MD, shares how she would treat a patient with early stage HER2-positive breast cancer.

More episodes of the podcast Oncology Learning Network

Navigating The Complexity of Melanoma Care: Part 6 21/05/2025

Navigating The Complexity of Melanoma Care: Part 5 21/05/2025

Navigating The Complexity of Melanoma Care: Part 4 21/05/2025

Navigating The Complexity of Melanoma Care: Part 3 21/05/2025

Navigating The Complexity of Melanoma Care: Part 2 21/05/2025

Navigating The Complexity of Melanoma Care: Part 1 21/05/2025

Community Education Program Improves Patient Education and Cancer Screening Rates 14/05/2025

Cholangioscopy: What Interventional Oncologists Need to Know Part 2 21/08/2024

Cholangioscopy: What Interventional Oncologists Need to Know 21/08/2024

Applications of AR in Interventional Oncology 20/06/2024

Ver todos los episodios